GlassScriptPhysician profile
Atiq Rehman
NPI 1457373730
$1,946.69
in general payments reported to CMS, 2019-2025
26 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $202 · 2021: $227 · 2022: $177 · 2023: $348 · 2024: $179 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685 · Travel and Lodging: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.91 |
| Travel and Lodging | $180.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $275.02 | 2021-2024 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $233.12 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $195.71 | 2020-2022 | |
| Intuitive Surgical, INC. | $180.33 | 2025 | |
| Abbott Laboratories | $142.19 | 2019-2023 | Proclaim |
| Allergan, INC. | $125.65 | 2019-2020 | |
| Medtronic, INC. | $89.17 | 2021-2023 | Intellis Adaptivestim |
| Avanos Medical | $78.72 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $76.66 | 2021 | |
| Stratus Medical, LLC | $76.19 | 2020 | |
| Collegium Pharmaceutical, INC. | $74.92 | 2019-2025 | Belbuca |
| Medtronic USA, INC. | $65.44 | 2019-2020 | |
| Boston Scientific Corporation | $50.98 | 2019 | |
| Atricure, INC. | $38.75 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Pacira Therapeutics, INC. | $35.11 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $29.06 | 2024 | |
| Scilex Pharmaceuticals INC. | $24.48 | 2025 | |
| Si-Bone, INC. | $23.79 | 2019 | |
| Stimwave Technologies Incorporated | $22.13 | 2022 | |
| Baxter Healthcare | $19.00 | 2023 | Floseal |
| Valinor Pharma, LLC | $18.99 | 2025 | Movantik |
| Foundation Fusion Solutions, LLC | $18.97 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.71 | 2022 | |
| Curonix LLC | $13.29 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $12.13 | 2019 | |
| Vertiflex, INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atiq Rehman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.